Search Results 1411-1420 of 16929 for Nortriptyline

  1. Fibromyalgia - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  3. Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  4. Belimumab With Rituximab for Primary Membranous Nephropathy (REBOOT) - Mayo Clinic

    The primary objective of this study is to determine the effectiveness of belimumab with rituximab at inducing a complete or partial remission (CR or PR) ...

  5. Mayo Clinic

    cc-feet-walking-upstairs-tablet ; About Mayo Clinic · About this Site · Contact Us ; Medical · AskMayoExpert · Clinical Trials ; Businesses · Executive Health ...

  6. Peripheral nerve injuries - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  7. Nystatin (vaginal route) - Side effects & dosage - Mayo Clinic

    Vaginal nystatin is used to treat fungus infections of the vagina. Nystatin vaginal cream or tablets may also be used for other problems as determined by your ...

  8. Clinical trials - Oncology (Medical)

    Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are ...

  9. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  10. Netarsudil significantly reduces intraocular pressure in patients with primary open-angle glaucoma - Mayo Clinic

    Intraocular pressure (IOP) reduction is key to controlling primary open-angle glaucoma (POAG), the second-leading cause of blindness worldwide.